Inactive Instrument
Cellivery Therapeutics, Inc. Stock
Stocks
A268600
KR7268600004
Biotechnology & Medical Research
| 1 day | -30.43% |
| Manager | Title | Age | Since |
|---|---|---|---|
Dae-Woong Cho
CEO | Chief Executive Officer | 58 | 28/08/2014 |
Byung-Hwa Lee
AUD | Comptroller/Controller/Auditor | 62 | 22/03/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Dae-Woong Cho
BRD | Director/Board Member | 58 | 28/08/2014 |
Yung-Ki Baek
BRD | Director/Board Member | 73 | 31/03/2023 |
Hyung Kim
BRD | Director/Board Member | 40 | 29/03/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -30.43% | -75.38% | - | - | 400K | |
| -3.00% | +0.33% | +77.39% | +109.41% | 73.96B | |
| +1.90% | +19.57% | +60.16% | +101.03% | 64.66B | |
| +0.55% | +1.64% | -5.15% | +471.68% | 27.32B | |
| +5.12% | +25.22% | +5.24% | -0.82% | 27.86B | |
| +2.74% | +11.55% | +66.56% | +27.34% | 25.97B | |
| +0.47% | +6.22% | +39.36% | -12.38% | 19.98B | |
| +1.82% | -3.11% | +245.72% | +423.83% | 17.84B | |
| +0.94% | +2.38% | +24.83% | +552.12% | 16.24B | |
| +0.73% | +5.54% | +39.71% | +153.07% | 13.3B | |
| Average | -2.01% | +6.16% | +61.53% | +202.81% | 31.9B | |
| Weighted average by Cap. | +0.60% | +6.66% | +60.77% | +162.00% |
Employees
-
